3SBio, (FRA:YFK) Interest Income : €0.0 Mil (TTM As of Dec. 2016)

View and export this data going back to . Start your Free Trial

What is 3SBio, Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. 3SBio,'s interest income for the six months ended in Dec. 2016 was €0.0 Mil. Its interest income for the trailing twelve months (TTM) ended in Dec. 2016 was €0.0 Mil.

3SBio, Interest Income Historical Data

The historical data trend for 3SBio,'s Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Interest Income Chart

3SBio, Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec14

Dec15

Dec16

Interest Income

Get a 7-Day Free Trial

2.22

3.14

3.16

4.77

3SBio, Semi-Annual Data
	Jun06	Dec06	Jun07	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
Interest Income	Get a 7-Day Free Trial															2.31	-	-	-	-

3SBio, Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

3SBio, (FRA:YFK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.3sbio.com

3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines